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Abstract
The effectiveness of transcranial photobiomodulation (tPBM) and methylene Blue (MB) in treating learning and memory
impairments is previously reported. In this study, we investigated the effect of tPBM and MB in combination or alone on
unpredictable chronic mild stress (UCMS)–induced learning and memory impairments in mice. Fifty-five male BALB/c mice
were randomly allocated to five groups: control, laser sham + normal saline (NS), tPBM + NS, laser sham + MB, and tPBM +
MB. All groups except the control underwent UCMS and were treated simultaneously for 4 weeks. Elevated plus maze (EPM)
was used to evaluate anxiety-like behaviors. Novel object recognition (NOR) test and Barnes maze tests were used to evaluate
learning and memory function. The serum cortisol and brain nitric oxide (NO), reactive oxygen species (ROS), total antioxidant
capacity (TAC), glutathione peroxidase (GPx), and superoxide dismutase (SOD) levels were measured by spectrophotometric
methods. Behavioral tests revealed that UCMS impaired learning and memory, and treatment with PBM, MB, and their com-
bination reversed these impairments. Levels of NO, ROS, SOD activity in brain, and serum cortisol levels significantly increased
while brain GPx activity and total antioxidant capacity significantly decreased in the sham +NS animals when compared with the
controls. A significant improvement was observed in treatment groups due to reversion of the aforementioned molecular analysis
caused by UCMS when it was compared with control levels. Both tPBM and MB in combination or alone have significant
therapeutic effects on learning and memory impairments in UCMS-received animals.
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Introduction
Due to fast-growing modernization and repeated and/or per-
sistent exposure to social challenges, chronic stress has been
considered to be a crucial mental health challenge and devel-
oping efficient, noninvasive, and low-cost therapeutic inter-
ventions is urgently required [1]. Chronic stress is a major
health concern and is considered to be a risk factor for devel-
oping several emotional distress such as depression, anxiety,
and cognitive-related dysfunctions such as learning and mem-
ory impairments [2]. Mitochondrial dysfunction is involved as
an underlying mechanism associated with chronic stress [3].
Mitochondrial oxidative phosphorylation is the main source
of reactive oxygen species (ROS) production, and the electron
transport chain (ETC) itself is susceptible to be damaged by
overproduction of ROS [4]. Given this, the oxidative damage
induced by chronic stress is the cause of the mitochondrial
impairment [3]. A study on mice showed that chronic stress
resulted in impaired spatial learning and memory as evaluated
by the Morris water maze (MWM) task [5].
Photobiomodulation (PBM) therapy involves the applica-
tion of low-power light from red to near-infrared (NIR) spec-
trums (600–1100 nm; powers < 500 mW) [6]. Transcranial
PBM (tPMB) therapy is a noninvasive intervention and its
neuroprotective potential is related to nonthermal and
neurostimulatory aspects [7]. Recently, there is a growing
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interest in expanding the indications for the brain application
of tPMB including neurological and psychiatric disorders [8].
It has also been revealed that tPBM is potential of decreasing
the hippocampal oxidative injury by improving the antioxi-
dant defense system in sleep-deprived mice [9]. PBM has a
significant effect on reduction of Aβ plaques and memory
improvements in treated animals after Aβ toxicity in hippo-
campus [10]. It was shown that the dose of 8 J/cm2 is more
beneficial in reversing anxiety- and depression-like behaviors
to normal condition [11]. The combined effect of tPBM and
metabolic modulators (e.g., pyruvate or lactate) has been in-
vestigated both in vitro and in vivo. Findings of this study
confirmed that the combinational treatment reversed the im-
paired memory of animals to a normal level [12]. The benefi-
cial applications of PBM combined with vitamin A and iron
nanoparticles were also demonstrated in animal models of
wound [13, 14]. A randomized studies in young adults con-
firmed that PBM combined with acute aerobic exercise is
beneficial for cognitive enhancement [15].
Methylene blue (MB) is a reduction-oxidation agent that at
low doses stimulates mitochondrial respiration by donating
electrons to the ETC [16]. MB as a mitochondrial neuropro-
tective agent readily crosses the blood-brain barrier (BBB)
and affects neural cells [17]. A substantial body of evidence
supports that systemically administered low-dose MB im-
proves neuronal mitochondrial cytochrome c oxidase (COX)
activity, oxygen consumption, brain glucose utilization, and
adenosine triphosphate (ATP) synthesis [18, 19]. Moreover,
the protective action of MB against neuronal oxidative stress
damage has been reported [20]. Recently, the therapeutic ef-
fect of MB in combination with hypothermia has been exam-
ined and improvement of spatial learning and memory was
observed in the combined treatment rats when compared with
single-treatment groups [21]. It has been suggested that the
interaction of tPBM and MP with the mitochondria leads to
the stimulation of ETC in the brain tissue [1]. It seems that
combined utilization of tPBM and MB can have beneficial
effects on damaged neuronal tissue.
In the current study, we aimed to investigate the potential
neuroprotective action of tPBM (as a photon donor) and MB
(as an electron donor) on mitochondrial dysfunction and spa-
tial and episodic-like memory impairment in the mice model
of unpredictable chronic mild stress (UCMS).
Material and methods
Animals and study design
Sixty male Balb/c mice, 8 weeks of age (25–30 g), were ob-
tained from the animal house of Tabriz University of Medical
Sciences (TUMS) (Tabriz, Iran). Animals were socially
housed in standard cages (five mice per cage) in a 12-h
light/12-h dark and temperature (23–25 °C) controlled condi-
tion, with the food and water ad libitum. After 1 week of
acclimatization, mice were randomized into the control (n =
12) and stress-induced groups (n = 48). The stress was in-
duced by exposure to the UCMS paradigm for four consecu-
tive weeks. Then, UCMS mice were randomly divided into 4
groups (n = 12 in each group) as follows: (i) sham (UCMS +
laser probe without irradiation) + normal saline (NS), (ii)
tPBM+NS, (iii) sham +MB, and (iv) tPBM+MB. Avolume
of 0.2 mL of NSwas injected intraperitoneally for each mouse
in the sham + NS and tPBM + NS groups.
UCMS paradigm
In order to induce stress, mice were subjected to the UCMS
paradigm for 4 weeks according to the method proposed by
Wang et al. [5]. Briefly, each week of the stress regime
consisted of different social and environmental stressors 2–3
times per day. The eight stress conditions were as follows: (1)
food deprivation for 24 h, (2) water deprivation for 24 h (with
exposure to empty bottle for the last 1 h), (3) overnight illu-
mination, (4) removal of sawdust for 24 h, (5) wet bedding for
24 h, (6) forced swimming at 18 °C water for 6 min, (7) tail
nipping for 1 min, and (8) physical restraint for 2 h. A timeline
of the procedures is depicted in Fig. 1.
Laser irradiation
A diode GaAlAs laser (Thor Photomedicine, Chesham, UK)
at 810-nm wavelength was applied for irradiation sessions.
The laser’s operation mode was Pulsed Wave (PW) on
10 Hz, 88% duty cycle, and average irradiance of 4.75 W/
cm2. A fluence of 8 J/cm2 was delivered to the cortical surface,
as previously described [22]. For transcranial laser irradiation,
the mouse was positioned on a plate and laser probe placed
over the head that covered the entire brain. Laser irradiation
was performed three times a week over a period of 4 weeks.
The UCMS group as sham-treated mice underwent identical
laser treatment but did not receive any laser irradiation.
Methylene blue treatment
The dye MB was obtained from Sigma–Aldrich (St.
Louis, MO, USA). Mice in the sham + MB and tPMB +
MB groups received a daily dose of MB (0.5 mg/kg body
weight; Intraperitoneal) for 4 consecutive weeks [23]. To
avoid unwanted toxic effects of laser irradiation after MB
administration [24], mice in the tPMB + MB group ini-
tially received laser treatment and after 2 h, MB was
injected.
Lasers Med Sci (2020) 35:573–584574
Behavioral analysis
Elevated plus maze test
The elevated plus maze (EPM) test evaluates anxiety-like and
exploratory behaviors in rodents and was carried out with the
same method shown previously by Patel and Hillard [25].
Briefly, the apparatus was comprised of two open (30 ×
5 cm) and two closed arms (30 × 5 × 15 cm) extending from
a central platform (5 × 5 cm) and elevated 40 cm from the
floor. The maze was positioned in the center of the room and
a video camera was located above the apparatus. Each mouse
was placed in the center of the maze, facing an enclosed arm,
and was allowed to freely explore it for 5 min. The maze was
cleaned with 70% ethanol solution between the individual
testing. All procedures took place in the morning (between
10:00 and 12:00 AM), in a room with controlled temperature
and light. The following behaviors were considered: (a) the
percentage of time spent in open arms (%OAT), (b) the per-
centage of entries to open arm (%OAE), and (c) the total arm
entries (TAE). The recordings were analyzed using a fully
automated video-tracking program Etho Vision™ (Noldus,
The Netherlands).
Novel object recognition test
The novel object recognition (NOR) test is a cognitive para-
digm that evaluates episodic-like memory. The test apparatus
consisted of a Plexiglas open-field box (30 × 30 × 30 cm) and
assembled objects (LEGO® blocks). The NOR test included
habituation, training, and retention sessions. Before the train-
ing session, each mouse was habituated to the empty arena for
10 min on the first day. One day after habituation, each mouse
was subjected to a training session in which two similar ob-
jects (A and A′) were located in the arena and the animal was
allowed to explore the arena and objects for 10 min. Retention
session performed 24 h after training, in this phase, the mouse
was returned to the same task, but one of the familiar objects
(A or A′) was replaced by a novel one (B). After each trial, the
apparatus was cleaned with 70% ethanol. The locomotor ac-
tivity and discrimination index (DI) were recorded by a video
camera fixed above the apparatus and scored using fully au-
tomated video-tracking program Etho Vision™ (Noldus,
The Netherlands) [26]. DI was calculated by the following
equation DI = (N − F)/(N + F), where N is the time of novel
object exploration and F is the time of familiar object
exploration.
Barnes maze task
The Barnes test was utilized to evaluate spatial learning and
memory. The procedure was as described previously [22]. The
test had three sessions, adaptation, training, and a probe trial
which was performed during 5 days. As adaptation and train-
ing sessions, each mouse was placed in the center of the maze
and allowed to explore the maze for 3 min in the presence of a
negative sound stimulus (80 dB), when the animal entered the
escape box, the buzzer was stopped and the animal allowed to
remain in it for 1 min. The maze was cleaned between the
trials with a 70% ethanol solution to prevent odor cues. On
the fifth day, a probe trial was carried out, that is, the escape
box was removed and mouse was placed in the center of the
maze for free activity. The parameters of interest were (a) the
escape latency time (the time to reach the target hole) during
the training sessions and (b) the time spent in the target quad-
rant, and (c) correct/wrong relative time during probe session,
which were measured using a video tracking program Etho
Vision™ (Noldus, The Netherlands).
Biochemical analysis
Sampling
Twenty-four hours after last behavioral test, mice in the ex-
perimental groups were decapitated after deep anesthesia with
a mixture of ketamine (75 mg/kg) and xylazine (10 mg/kg).
For each mouse, blood sample was taken and centrifuged for
Fig. 1 The schematic view of the study including the application of
UCMS and tPBM and MB treatments. EPM and NOR behavioral tests
were performed on day 29 and day 30, respectively. Barnes maze test was
also performed in days 31 to 35. At the end of this study (day 36), brain
samples were prepared for molecular analysis. UCMS, unpredictable
chronic mild stress; tPBM, transcranial photobiomodulation; MB,
methylene blue; EPM, elevated plus maze; NOR, novel object
recognition; NS, normal saline
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serum obtaining. The brain tissues were immediately removed
and kept in the refrigerator under−70 °C.
ROS production
Dichlorohydrofluorescein diacetate (DCFDA) was utilized as
a fluorescent dye to measure the ROS production level in the
brain. The mitochondria were incubated with 2-mM DCFDA
at 37 °C for 20 min. A fluorescence microplate reader was
used to determine the fluorescence intensity. ROS levels were
represented as fluorescence intensity and normalized to sam-
ples protein.
Nitric oxide production
Sample preparation started with the pulverization of brain tis-
sue with liquid nitrogen, and then, 30 s of homogenization
with 1 mL of cold phosphate-buffered saline (PBS) on the
ice was done. The resultants were centrifuged for 10 min at
4 °C (10,000 r/min) and were kept at − 80 °C. The enzyme-
linked immunosorbent assay (ELISA) kit of mouse nitric ox-
ide (NO) was provided by Hangzhou Eastbiopharm Co., Ltd.
(Hangzhou, China). The manufacturer’s ELISA kit guidelines
were used to perform the measurements. NO levels were stat-
ed as micromoles per milligram of protein.
Antioxidant activity measurement
The brain samples were homogenized with 1.15% KCl and
centrifuged for 10 min at 4 °C (10,000 r/min) and kept under
− 80 °C. RANSOD (Randox Laboratories Ltd., Crumlin, UK)
laboratory kit was utilized to determine the activity of super-
oxide dismutase (SOD). A spectrophotometer was used to
measure the absorbance at 505-nm wavelength, as stated in
the manufacturer’s guidelines. Glutathione peroxidase (GPx)
activity of cerebral tissue was measured using the RANSOD
(Randox Laboratories Ltd., Crumlin, UK) assay kit. In order
to calculate the concentration of GPx, a spectrophotometer
was utilized to measure the reduction in absorbance at
340 nm (37 °C) [27]. Randox total antioxidant status kit
(Randox Laboratories Ltd., Crumlin, UK) was also used to
measure the total antioxidant capacity (TAC). Changes in
the absorbance at 600 nm caused by the variation in the sam-
ple’s color were measured [28].
The activity values of GPx and SOD in the cerebral tissue
were stated as units per milligram of protein. The value of
TAC in the brain was also stated as millimoles per liter.
Serum cortisol levels determination
The serum cortisol level was measured using a cortisol-specific
kit (Catalog No. RE52611, from the IBL International Cortisol
Saliva, Germany), according to the manufacturer’s instructions.
To avoid fluctuations in cortisol concentrations due to circadian
rhythms, blood samples were collected in the morning.
Statistical analysis
All analyzed data were presented as mean ± standard error of
the mean (SEM). One-way analysis of variance (ANOVA)
followed by the Tukey post hoc test was utilized to compare
the differences between groups. Moreover, to draw a compar-
ison between groups in the Barnes maze test, the two-way
repeated measurement ANOVA was utilized. The statistical
analyses were carried out using GraphPad Prism software
(version 6), and p < 0.05 was considered to be significant.
Results
Effect of tPBM and MB on anxiety-like behaviors
in the EPM test
Statistical analysis revealed that UCMS significantly de-
creased both %OAT (p < 0.01) and %OAE (p < 0.0001) in
the EPM test. However, tPBM or MB alone and in combina-
tion significantly increased both the %OAT and %OAE when
compared with the sham + NS group. (Fig. 2). In addition,
there was no statistically significant difference between
groups in TAE in this test (data not shown).
Effect of tPBM and MB on episodic memory
in the novel object recognition test
NOR test analysis showed that there was no significant differ-
ence between the novel and familiar object exploration time in
the sham +NS group, which indicated episodic memory impair-
ment.Whereas, both tPBM (p < 0.01) andMB (p < 0.001) treat-
ments significantly increased novel object exploration time.
Moreover, the tPBM + NS (p < 0.001), sham + MB (p < 0.01),
and tPMB + MB (p < 0.001) groups showed a significant in-
crease in DI, while the sham + NS group with negative values
had lower DI than the controls (p< 0.0001), indicating an im-
pairment in episodic memory (Fig. 3). Furthermore, there were
no significant differences between groups in locomotor activity
and total observations in this test (data not shown).
Effect of tPBM and MB on spatial learning
and memory in the Barnes maze test
Results analysis showed a decrease in the latency time during
4 days of training in all groups. The sham + NS animals had the
highest latency time on day 4. These data suggest that UCMS
induction impairs spatial learning performance, whereas both
tPBM and MB treatments significantly (p < 0.05) increased la-
tency timewhen compared with the Sham +NS animals (Fig.4).
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The time spent of the sham + NS animals in the target
quadrant was significantly (p < 0.01) lesser than the control
group in probe session. The correct/wrong relative time in
the sham + NS animals was significantly (p < 0.001) lower
than the control group. Moreover, the tPBM + NS
(p < 0.05), sham + MB (p < 0.05), and tPMB + MB
(p < 0.001) groups had a significantly higher correct/wrong
relative time when compared with the sham + NS group
(Fig. 5).
Effect of tPBM and MB on serum cortisol levels
Results analysis revealed that treatment with tPBM and tPBM
+ MB had a significant effect on serum levels of cortisol in
UCMS-received animals. Several comparisons between
groups indicated that serum level of cortisol was significantly
higher in the sham + NS animals (p < 0.0001) and treatment
with tPBM (p < 0.01) and combined therapy (p < 0.0001)
could significantly reduce it. Combination therapy with MB
Fig. 3 The effect of treatments on UCMS in episodic memory in the
NOR test. a The exploration time of the novel object. The left and right
columns of each group represent the exploration time of familiar and
novel object , respect ively. **p < 0.01, ***p < 0.001, and
****p < 0.0001 between the novel and the familiar exploration time of
each group. b The values of DI. ####p < 0.0001 in comparison with
control group and **p < 0.01 and ***p < 0.001 in comparison with
sham + NS group. MB, methylene blue; NS, normal saline; tPBM,
transcranial photobiomodulation; UCMS, unpredictable chronic mild
stress; NOR, novel object recognition; DI, discrimination index
Fig. 2 The effect of treatments on UCMS in anxiety-like behavior in
EPM task ####p < 0.0001 and ##p < 0.01 when compared with the con-
trols, and *p < 0.05, ***p < 0.001, and ****p < 0.0001 when compared
with the sham + NS group. MB, methylene blue; NS, normal saline;
OAE, open arm entry; OAT, open arm time; tPBM, transcranial
photobiomodulation; UCMS, unpredictable chronic mild stress; EPM,
elevated plus maze
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and tPBM also significantly (p < 0.001) decreased serum
levels of cortisol when compared with single therapy (Fig. 6).
Effect of tPBM and MB on brain NO levels
Results showed that treatment with tPBM and MB had a sig-
nificant effect on brain NO levels in the UCMS-received an-
imals. Several comparisons between groups indicated that NO
level was significantly higher in the sham + NS animals when
compared with the control group (p < 0.0001), and treatment
with MB and tPBM lonely or in their combination could sig-
nificantly decrease the level of NO in the brain (Fig.7).
Effect of tPBM and MB on the brain ROS
The analysis of results revealed that treatment with tPBM and
MB in UCMS-received animals had a significant effect on
brain ROS levels. Comparisons between groups indicated that
Fig. 5 The evaluation of short-term spatial memory in probe session of
Barnes maze test. a The time spent in the target quadrant. b Correct/
wrong relative time. ##p < 0.01 and ###p < 0.001 in comparison with con-
trol animals and *p < 0.05, **p < 0.01, and ***p < 0.001 in comparison
with sham + NS group. MB, methylene blue; NS, normal saline; tPBM,
transcranial photobiomodulation; UCMS, unpredictable chronic mild
stress
Fig. 4 The escape latency time
during 4 days in the study groups.
#p < 0.05 when compared with
control animals and *p < 0.05
compared with sham + NS group
on the corresponding days. MB,
methylene blue; NS, normal
saline; tPBM, transcranial
photobiomodulation; UCMS,
unpredictable chronic mild stress
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brain ROS level was significantly increased in the sham + NS
animals (p < 0.0001) when compared with controls and treat-
ment with tPBM (p < 0.001), MB (p < 0.01), and combination
therapy (p < 0.0001), significantly decreasing ROS levels in
the brain tissue. Furthermore, combination therapy signifi-
cantly (p < 0.05) decreased brain ROS levels compared with
the sham + MB group (Fig. 8a).
Effect of tPBM and MB on total antioxidant capacity
Results showed that treatment with tPBM and MB in the
UCMS-received animals had a significant effect on TAC. A
number of comparisons between groups indicated that total
antioxidant activity was significantly lesser than controls in
the sham + NS animals (p < 0.01) and treatment with MB
(p < 0.01), tPBM (p < 0.01), and combined therapy
(p < 0.0001), significantly increasing the brain TAC (Fig. 8b).
Effect of tPBM and MB on brain GPx and SOD
activities
Results revealed that animals in UCMS condition and treat-
ment with tPBM andMB had a significant effect on brain GPx
activity. Multiple comparisons between groups indicated that
brain GPx activity in the sham + NS animals was significantly
lower than the control animals (p < 0.001), and treatment with
MB and tPBM could significantly increase GPx activity
(p < 0.01). Furthermore, the GPx activity of combination
treatment was significantly (p < 0.001) higher than the sham
+ NS animals (Fig. 8c).
Results also indicated that animals in UCMS condition and
treatment with tPBM and MB had a significant effect on brain
SOD activity. A number of comparisons between groups in-
dicated that brain SOD activity in the sham + NS animals was
significantly higher than in the controls (p < 0.05), and treat-
ment with MB and tPBM could significantly decrease the
brain SOD activity raised by UCMS (p < 0.01). The combined
treatment with MB and tPBM was capable of decreasing the
Fig. 7 The evaluation of nitric
oxide (NO) in the brain tissue.
####p < 0.0001 in comparison
with control animals and
***p < 0.001 and ****p < 0.0001
in comparison with sham + NS
group. MB, methylene blue; NS,
normal saline; tPBM, transcranial
photobiomodulation; UCMS, un-
predictable chronic mild stress
Fig. 6 The evaluation of serum cortisol level. ####p < 0.0001 in
comparison with control animals and **p < 0.01 and ****p < 0.0001
compared with sham + NS group and ††p < 0.01 in comparison with
single treatments. MB, methylene blue; NS, normal saline; tPBM,
transcranial photobiomodulation; UCMS, unpredictable chronic mild
stress
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SOD activities in the brain tissue more significantly
(p < 0.001) (Fig. 8d).
Discussion
Despite the promising studies on the benefits of tPBM and
MB, the combined effects and underlying mechanisms of
these treatments are not understood precisely. The combina-
tion treatments can enhance both time and efficiency of ther-
apy. In this study, a conventional UCMS animal model was
used to determine the effect of tPBM and MB on anxiety-like
behaviors, spatial and episodic memories, and antioxidative
activities. Our results indicated that tPBM and MB and their
combination were beneficial in treating UCMS-induced anx-
iety-like behaviors, learning and memory impairments, brain
oxidative stress, and NO production, as well as serum cortisol
levels.
Decreased %OAT and %OAE in EPM test and increased
serum levels of cortisol in the sham + NS group indicated
anxiety induction in these animals. Animals’ performance in
the Barnes maze task was also impaired, which confirmed
spatial memory disturbance. These changes, however, were
significantly reversed by tPBM and MB treatments alone or
in combination.
This study also indicated that UCMS induction increased
brain NO levels and tPBM and MB treatment alone or in
combination decreased NO production. It has been shown that
NO is excessively and permanently synthesized in the brain
during stress [3]. In addition, the concentration of NO in the
hypothalamus has largely linked to the development of learn-
ing and memory performances [29]. On the other hand, these
Fig. 8 The evaluation of a ROS, b TAC levels, and c GPx and d SOD
activities in the brain tissue. #p < 0.05, ##p < 0.01, ###p < 0.001, and
####p < 0.0001 compared with the control animals, **p < 0.01,
***p < 0.001, and ****p < 0.0001 in comparison with sham + NS
group and †p < 0.05 in comparison with sham + MB group. MB,
methylene blue ; NS, normal sa l ine ; tPBM, transcrania l
photobiomodulation; UCMS, unpredictable chronic mild stress; ROS,
reactive oxygen species; TAC, total antioxidant capacity; GPx,
glutathione peroxidase; SOD, superoxide dismutase
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effects become predominant when the low concentration of
NO is produced. In this respect, remarkable memory impair-
ment has been observed due to a large increase in the concen-
tration of NO in rats’ brain [30].
The mitochondrial respiratory chain is located in the inner
mitochondrial membrane [31]. Mitochondrial respiratory
chain complexes show less activity after CMS in the brain
[32]. Highly reactive radicals can harm proteins, lipids, and
DNA in the mitochondria [33], which subsequently causes
dysfunction of complex I or III [34] and results in metabolic
oxidative stress as well as cellular damage [35]. Low-dose
MB and PBM stimulate mitochondrial respiration by donating
electrons and photons respectively to the electron transport
chain [1]. These donating of electrons and photons results in
better function of the respiratory chain and lesser production
of free radicals (Fig. 9).
The present study also showed that UCMS induction de-
creased GPx activity and TAC and increased ROS levels in the
brain tissue, while tPBM and MB inhibited ROS production
induced by UCMS. The major consequences of oxidative
stress in a living cell is the production of ROS and reduction
in the antioxidant concentration [36]. There is an obvious in-
consistency in the literature about the effect of PBM on ROS
production. Some studies in diverse cell types have reported
the generation of ROS after PBM [37]. However, other studies
have shown the reduction of ROS concentration and amelio-
ration of oxidative stress [38]. Delivering an optimum dose of
the laser light to unstressed normal cells in culture results in the
production of ROS in mitochondria and a rise in mitochondrial
membrane potential (MMP) [37, 39]. Conversely, a rise in
ROS concentration is also related to a reduction in MMPwhen
mitochondrial inhibitors or oxidative stressors are employed
[40]. In the former example, the irradiation of laser to the cells
results in an elevation of MMP and consequently the reduced
generation of ROS by the mitochondria.
SOD and GPx are the most important antioxidant enzymes
that act as the pioneer of an antioxidant defense system against
ROS during oxidative damage and have an essential role in
cognitive functions [41]. Scientists have recently focused on
the role of GPx deficit in the pathophysiology of stressed
conditions. In one study, a lower GPx activity was observed
in stressed animals compared with the controls [42]. In anoth-
er study, patients with affective disorders had a lower GPx
activity compared with controls [43]. Poor GPx activity can
result in weakened protection against oxidants and therefore
noticeable damage to membrane fatty acids and functional
proteins which in turn results in neurotoxic damage associated
with persistent or severe illness [44].
SOD is known as one of the main antioxidant enzymes.
However, the results of studies on stressed conditions are not
consistent. Some studies stated that the activity of SOD is low
under stressed conditions [45, 46]. However, one study report-
ed a raised SOD activity associated with the intensity of de-
pression [47]. Patients with depression have greater SOD1
activity than the healthy controls during the acute phase of
illness [48]. In addition, the augmented activity of SOD has
been reported in the prefrontal cortex of patients with depres-
sive disorder [49]. It seems that an elevated level of SOD
activity is a mechanism by defense system against an in-
creased level of free radicals such as ROS in stressed condi-
tions. At the first glance, this seems to be a contradictory
result. The stage or duration of illness could be an important
factor to explain the variances in this contradictory outcome
[50]. In addition, SOD serves to catalyze the removal of the
toxic superoxide radical [51]. Therefore, greater activity of
SOD in depressed patients is possibly associated with higher
concentration of oxidative mediators. Moreover, there might
be a biphasic response in the generation of ROS that is the
cause of variances between studies [50]. According to previ-
ous studies, larger amounts of GPx and SOD and
Fig. 9 Schematic of tPBM and
MB therapeutic effects on the
respiratory chain and mechanisms
in the brain. NIR, near infrared;
MB, methylene blue. The figure
was created in theMind the Graph
platform, www.mindthegraph.
com
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improvement in learning and memory performance were ob-
served in sleep-deprived animals after tPBM when compared
with controls [9]. Combined therapy with tPBM and coen-
zyme Q10 also has the potentiality to reverse GPx and SOD
levels to normal conditions in stressed animals [52].
In this study, the therapeutic effects of combination treat-
ment in most measurements were as similar as the single treat-
ments possibly because the single therapies fully brought back
the harmful effects of UCMS to control levels. This phenom-
enon was observed in some other studies. For example, in a
study by Dong et al., when ROS and ATP levels of hippocam-
pus were measured after single or combined treatments with
LLLT and/or pyruvate-lactate in traumatic brain injury model
of mice, the levels of ATP in combined groups were fully
backed to control levels and were also significantly different
with single treatments. But the levels of ROS in all treatment
groups (including LLLT, pyruvate, lactate, and their combina-
tions) was the same as the control group, and there was no
significant difference between single and combined treat-
ments [12]. In another study by Salehpour et al., no significant
difference was observed in levels of GPx, SOD, and TAC
between single and combined treatments with PBM and co-
enzyme Q10 maybe because single therapy was fully brought
back to control levels [52]. In our study, no significant differ-
ence was observed between single and combined therapy rath-
er than the serum cortisol level and ROS probably because the
single therapies were capable of completely treating the harm-
ful effects of UCMS. This might also be related to the type of
stress model and the dosage of each of the single therapies that
are used in this study. More combination studies with different
dosages in neuropsychological disorders are necessary to dis-
cover the hidden aspects and the establishment of this method.
Acknowledgments This article was derived from the MSc dissertation of
Mr. Reza Meynaghizadeh-Zargar.






UCMS unpredictable chronic mild stress
EPM elevated plus maze
NOR novel object recognition test
MWM Morris water maze
TAE the total arm entries




ROS reactive oxygen species
GPx glutathione peroxidase
SOD superoxide dismutase
TAC total antioxidant capacity
ETC electron transport chain
BBB blood-brain barrier
COX cytochrome c oxidase
ATP adenosine triphosphate
MMP mitochondrial membrane potential
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